Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Thermo Fisher Scientific Inc | TMO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 293.53 | 0.00 | 0.00 | 0.00 | 293.53 | 03:59:41 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.00 | USD |
Thermo Fisher Scientific Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 117.70B | 400.99M | $ 2.94B | 7.24 | 33.10 | 399.11M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 3.93M | $ 0.68 | 0.23% | 12/16/19 | - | - |
Thermo Fisher Scientific News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TMO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 299.90 | 300.00 | 290.64 | 293.58 | 1,126,274 | -6.37 | -2.12% |
| 1 Month | 286.07 | 306.00 | 279.32 | 292.71 | 1,258,773 | 7.46 | 2.61% |
| 3 Months | 278.00 | 306.00 | 267.46 | 287.43 | 1,448,515 | 15.53 | 5.59% |
| 6 Months | 262.92 | 306.00 | 258.03 | 284.03 | 1,452,048 | 30.61 | 11.64% |
| 1 Year | 242.49 | 306.00 | 208.34 | 266.33 | 1,513,074 | 51.04 | 21.05% |
| 3 Years | 152.52 | 306.00 | 139.07 | 216.30 | 1,396,387 | 141.01 | 92.45% |
| 5 Years | 117.92 | 306.00 | 117.10 | 182.17 | 1,450,435 | 175.61 | 148.92% |
Thermo Fisher Scientific Description
| Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments: analytical technologies (23% of sales); specialty diagnostic products (15%); life science solutions (26%); and lab products and services (41%). |
